Ramin S. Herati

9.7k total citations
35 papers, 1.6k citations indexed

About

Ramin S. Herati is a scholar working on Immunology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Ramin S. Herati has authored 35 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 9 papers in Infectious Diseases and 8 papers in Molecular Biology. Recurrent topics in Ramin S. Herati's work include T-cell and B-cell Immunology (13 papers), Immune Cell Function and Interaction (11 papers) and SARS-CoV-2 and COVID-19 Research (9 papers). Ramin S. Herati is often cited by papers focused on T-cell and B-cell Immunology (13 papers), Immune Cell Function and Interaction (11 papers) and SARS-CoV-2 and COVID-19 Research (9 papers). Ramin S. Herati collaborates with scholars based in United States, Netherlands and Germany. Ramin S. Herati's co-authors include E. John Wherry, Bertram Bengsch, Laura A. Vella, Katherine P. Ponder, Marie I. Samanovic, Mark J. Mulligan, Takuya Ohtani, Niels Bovenschen, Kyong‐Mi Chang and David H. Canaday and has published in prestigious journals such as The Journal of Experimental Medicine, Immunity and Nature Immunology.

In The Last Decade

Ramin S. Herati

35 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ramin S. Herati United States 23 767 392 335 286 256 35 1.6k
Katherine Jackson Australia 26 1.5k 1.9× 270 0.7× 793 2.4× 318 1.1× 152 0.6× 60 2.4k
Naomi McGovern United Kingdom 17 1.2k 1.5× 148 0.4× 353 1.1× 156 0.5× 180 0.7× 28 1.8k
Xianfang Wu United States 20 672 0.9× 390 1.0× 972 2.9× 551 1.9× 90 0.4× 37 2.2k
Paul A Santini United States 8 1.0k 1.3× 187 0.5× 524 1.6× 129 0.5× 141 0.6× 12 1.7k
Masayuki Kuraoka United States 20 1.2k 1.6× 218 0.6× 455 1.4× 480 1.7× 61 0.2× 44 1.8k
Søren E. Degn Denmark 22 1.5k 2.0× 135 0.3× 346 1.0× 188 0.7× 169 0.7× 55 2.0k
Anna Cerny United States 25 1.0k 1.3× 304 0.8× 518 1.5× 606 2.1× 96 0.4× 29 1.9k
Daniele Moratto Italy 20 829 1.1× 330 0.8× 239 0.7× 195 0.7× 75 0.3× 54 1.5k
Denis Hudrisier France 31 2.3k 3.0× 269 0.7× 530 1.6× 254 0.9× 112 0.4× 54 2.8k
Nicole A. de Weerd Australia 18 1.2k 1.6× 259 0.7× 457 1.4× 261 0.9× 115 0.4× 31 2.1k

Countries citing papers authored by Ramin S. Herati

Since Specialization
Citations

This map shows the geographic impact of Ramin S. Herati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ramin S. Herati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ramin S. Herati more than expected).

Fields of papers citing papers by Ramin S. Herati

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ramin S. Herati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ramin S. Herati. The network helps show where Ramin S. Herati may publish in the future.

Co-authorship network of co-authors of Ramin S. Herati

This figure shows the co-authorship network connecting the top 25 collaborators of Ramin S. Herati. A scholar is included among the top collaborators of Ramin S. Herati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ramin S. Herati. Ramin S. Herati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oom, Aaron L., Heekoung Youn, Michael Tuen, et al.. (2025). The two-dose MVA-BN mpox vaccine induces a nondurable and low avidity MPXV-specific antibody response. Journal of Virology. 99(9). e0025325–e0025325. 7 indexed citations
2.
Monteiro, Clarice, Marie I. Samanovic, Amber Cornelius, et al.. (2024). SARS-CoV-2 inflammation durably imprints memory CD4 T cells. Science Immunology. 9(96). eadj8526–eadj8526. 5 indexed citations
3.
Coz, Carole Le, Derek A. Oldridge, Ramin S. Herati, et al.. (2023). Human T follicular helper clones seed the germinal center–resident regulatory pool. Science Immunology. 8(82). eade8162–eade8162. 36 indexed citations
4.
Samanovic, Marie I., Amber Cornelius, Joseph R. Allen, et al.. (2022). Robust immune responses are observed after one dose of BNT162b2 mRNA vaccine dose in SARS-CoV-2–experienced individuals. Science Translational Medicine. 14(631). eabi8961–eabi8961. 45 indexed citations
5.
Samanovic, Marie I., Aaron L. Oom, Amber Cornelius, et al.. (2022). Vaccine-Acquired SARS-CoV-2 Immunity versus Infection-Acquired Immunity: A Comparison of Three COVID-19 Vaccines. Vaccines. 10(12). 2152–2152. 12 indexed citations
6.
Tada, Takuya, Belinda M. Dcosta, Marie I. Samanovic, et al.. (2021). Convalescent-Phase Sera and Vaccine-Elicited Antibodies Largely Maintain Neutralizing Titer against Global SARS-CoV-2 Variant Spikes. mBio. 12(3). e0069621–e0069621. 46 indexed citations
7.
Buus, Terkild B., Alberto Herrera, Ellie Ivanova, et al.. (2021). Improving oligo-conjugated antibody signal in multimodal single-cell analysis. eLife. 10. 32 indexed citations
8.
Tada, Takuya, Hao Zhou, Belinda M. Dcosta, et al.. (2021). High-titer neutralization of Mu and C.1.2 SARS-CoV-2 variants by vaccine-elicited antibodies of previously infected individuals. Cell Reports. 38(2). 110237–110237. 14 indexed citations
9.
Bengsch, Bertram, Takuya Ohtani, Omar Khan, et al.. (2018). Epigenomic-Guided Mass Cytometry Profiling Reveals Disease-Specific Features of Exhausted CD8 T Cells. Immunity. 48(5). 1029–1045.e5. 183 indexed citations
10.
Herati, Ramin S., Alexander Muselman, Laura A. Vella, et al.. (2017). Successive annual influenza vaccination induces a recurrent oligoclonotypic memory response in circulating T follicular helper cells. Science Immunology. 2(8). 107 indexed citations
11.
Sayın, Ismail, Andrea J. Radtke, Laura A. Vella, et al.. (2017). Human T follicular regulatory cells (Tfr) able to inhibit antibody production are enriched at the lymph node T-B border and rare in germinal centers. The Journal of Immunology. 198(Supplement_1). 152.7–152.7. 1 indexed citations
12.
Naradikian, Martin S., Arpita Myles, Daniel P. Beiting, et al.. (2016). Cutting Edge: IL-4, IL-21, and IFN-γ Interact To Govern T-bet and CD11c Expression in TLR-Activated B Cells. The Journal of Immunology. 197(4). 1023–1028. 177 indexed citations
13.
Herati, Ramin S., Morgan A. Reuter, Douglas V. Dolfi, et al.. (2014). Circulating CXCR5+PD-1+ Response Predicts Influenza Vaccine Antibody Responses in Young Adults but not Elderly Adults. The Journal of Immunology. 193(7). 3528–3537. 125 indexed citations
14.
Herati, Ramin S. & Emily A. Blumberg. (2012). Losing ground. Current Opinion in Infectious Diseases. 25(4). 445–449. 32 indexed citations
15.
Herati, Ramin S., Van W. Knox, Patricia O’Donnell, et al.. (2008). Radiographic evaluation of bones and joints in mucopolysaccharidosis I and VII dogs after neonatal gene therapy. Molecular Genetics and Metabolism. 95(3). 142–151. 40 indexed citations
16.
Herati, Ramin S., et al.. (2008). Improved retroviral vector design results in sustained expression after adult gene therapy in mucopolysaccharidosis I mice. The Journal of Gene Medicine. 10(9). 972–982. 24 indexed citations
17.
Ma, Xiucui, Yuli Liu, Anne K. Hennig, et al.. (2007). Improvements in Mucopolysaccharidosis I Mice After Adult Retroviral Vector–mediated Gene Therapy with Immunomodulation. Molecular Therapy. 15(5). 889–902. 50 indexed citations
18.
Traas, Anne M., Ping Wang, Xiucui Ma, et al.. (2007). Correction of Clinical Manifestations of Canine Mucopolysaccharidosis I with Neonatal Retroviral Vector Gene Therapy. Molecular Therapy. 15(8). 1423–1431. 80 indexed citations
19.
Herati, Ramin S., et al.. (2004). Synthesis of 1‐methoxypoly(oxyethylene)benzocyclobutene and its diels–alder reactions. Journal of Polymer Science Part A Polymer Chemistry. 42(8). 1934–1938. 3 indexed citations
20.
Liu, Yuli, Lingfei Xu, Anne K. Hennig, et al.. (2004). Liver-directed neonatal gene therapy prevents cardiac, bone, ear, and eye disease in mucopolysaccharidosis I mice. Molecular Therapy. 11(1). 35–47. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katherine Jackson Breakdown of academic impact, for papers by Naomi McGovern Breakdown of academic impact, for papers by Xianfang Wu Breakdown of academic impact, for papers by Paul A Santini Breakdown of academic impact, for papers by Masayuki Kuraoka Breakdown of academic impact, for papers by Søren E. Degn Breakdown of academic impact, for papers by Anna Cerny Breakdown of academic impact, for papers by Daniele Moratto Breakdown of academic impact, for papers by Denis Hudrisier Breakdown of academic impact, for papers by Nicole A. de Weerd
Rankless by CCL
2026